Professor Dr.Merlin Thomas , a physician scientist at the Baker IDI Heart and Diabetes Institute in Melbourne, Australia gave an exciting insight into the latest clinical trial proving cardiac safety of DPP4 inhibitor at the Doctors�CME held at Taj Vivanta on 2nd September 2013. His deliberation was on �DPP4 inhibitors: no time for compromise�. Dr.Jothydev Kesavadev presented �Patient centered approach: case study� where he discussed using case studies the uniqueness of DPP4 inhibitors. Dr.K.P.Paulose was the chairperson for the CME. Professor Merlin also made a facility visit to JDC.